Family Site

The contents provided by this page is intended for patients prescribed with Remsima® subcutaneous(SC). If you are an Australian Healthcare Professional , please click the relevant button.

About Remsima® How Remsima® works

How Remsima® works

Remsima® Mode of Action1

Remsima® contains the active substance called infliximab.
Remsima® which is a monoclonal antibody that attaches to a chemical messenger in the body called tumor necrosis factor alpha (TNF-alpha), involved in causing inflammation. By blocking TNF-alpha, Remsima® improves inflammation and other disease symptoms.

References

1. Remsima® Summary of Product Characteristics. Available at: https://www.ema.europa.eu/en/documents/product-information/Remsima®-epar-product-information_en.pdf Accessed 4 Sep 2020.

Abbreviations

TNF-α: tumor necrosis factor alpha